Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.590
-0.030 (-1.85%)
At close: Mar 28, 2025, 4:00 PM
1.614
+0.023 (1.48%)
Pre-market: Mar 31, 2025, 8:09 AM EDT

Aclaris Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-132.07-88.48-86.91-90.87-51.02
Upgrade
Depreciation & Amortization
0.810.860.80.921.32
Upgrade
Asset Writedown & Restructuring Costs
86.916.63---
Upgrade
Stock-Based Compensation
10.8620.5415.0414.0611.21
Upgrade
Other Operating Activities
2.5-27.274.725.092.21
Upgrade
Change in Accounts Receivable
-0.020.190.140.154.9
Upgrade
Change in Accounts Payable
-4.19-1.470.373.66-5.22
Upgrade
Change in Unearned Revenue
23.93----
Upgrade
Change in Other Net Operating Assets
-8.810.68-1.7-5.15-2.04
Upgrade
Operating Cash Flow
-20.08-78.33-67.57-52.13-38.63
Upgrade
Capital Expenditures
-0.12-1.31-0.61-0.31-0.45
Upgrade
Sale (Purchase) of Intangibles
-35.81----
Upgrade
Investment in Securities
-33.8447.5313.23-167.326.84
Upgrade
Investing Cash Flow
-69.7746.2212.63-167.636.39
Upgrade
Long-Term Debt Issued
----10.91
Upgrade
Long-Term Debt Repaid
----11.48-0.14
Upgrade
Net Debt Issued (Repaid)
----11.4810.78
Upgrade
Issuance of Common Stock
80.0327.6372.9239.667.81
Upgrade
Repurchase of Common Stock
-0.41-0.1-0.03-3.12-
Upgrade
Other Financing Activities
-5.09-0.83---0.21
Upgrade
Financing Cash Flow
74.5426.7172.87225.0518.37
Upgrade
Net Cash Flow
-15.31-5.417.935.29-13.87
Upgrade
Free Cash Flow
-20.2-79.63-68.17-52.44-39.09
Upgrade
Free Cash Flow Margin
-107.89%-254.84%-229.13%-775.65%-602.99%
Upgrade
Free Cash Flow Per Share
-0.26-1.14-1.04-0.92-0.92
Upgrade
Levered Free Cash Flow
-59.12-37.97-39.31-28.51-18.59
Upgrade
Unlevered Free Cash Flow
-59.12-37.97-39.31-28.51-18.59
Upgrade
Change in Net Working Capital
2.02-13.51.322.320.35
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q